Sofosbuvir therapy may be cost-effective for certain hepatitis C patients
1. From a computer simulation, sofosbuvir-based regimens may be more cost-effective in patients with cirrhosis or previously treated with interferon. ...
1. From a computer simulation, sofosbuvir-based regimens may be more cost-effective in patients with cirrhosis or previously treated with interferon. ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Efficacy ...
1. Simulation studies for the new hepatitis C virus (HCV) treatments sofosbuviir and ledispavir show gains in cost-effectiveness, but may ...
1. From a computer simulation, the novel drug regimen of sofosbuvir and ledipasvir was the most cost-effective treatment strategy for ...
1. Medical decision making in patients with hepatitis C (HCV) may be aided by knowing the likely rate of liver ...
Originally published by Harvard Health. What Is It? Hepatitis C is a viral infection. It can inflame and damage the liver. ...
1. Activated suicide gene modified lymphocytes (SGMLs) inhibit Hepatitis C virus (HCV) replication multiple in vitro models of infection. 2. ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. An ...
1. 33 out of 34 post-liver transplant hepatitis C virus (HCV) patients treated with the trial regimen (ombitasavir, ABT-450/r, dasabuvir, ...
1. Sofosbuvir plus ledipasvir was effective in treating chronic hepatitis C virus (HCV) genotype 1 infection in patients who were ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.